Clinical trial
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department…
NCT00274170 · C.R.Darnall Army Medical Center, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00274170 |
|---|---|
| Title | Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache |
| Official title | Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache |
| Lead sponsor | C.R.Darnall Army Medical Center, U.S. Fed |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Migraine Headache |
| Intervention type | Drug |
| Interventions | Octreotide |
| Enrollment | 56 |
| Start date | Jan 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Jan 10, 2006 |
| Last update posted | Mar 1, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: